This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Chuan Yu: Innovator in Dentinogenesis Imperfecta Research
Introduction
Chuan Yu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of dental genetics, particularly in the diagnosis and treatment of dentinogenesis imperfecta type II (DGI-II). His innovative work has the potential to improve the lives of individuals affected by this genetic condition.
Latest Patents
Chuan Yu holds a patent for a method of diagnosing and treating dentinogenesis imperfecta type II by using the dentin sialophosphoprotein (DSPP) gene and its coded product. The invention outlines a method for diagnosing DGI-II and DGI-II with deafness by detecting variations in the DSPP gene, transcript, and/or protein. This method allows for a more accurate assessment of the likelihood of suffering from these conditions compared to the normal population. Additionally, the patent includes a pharmaceutical composition for treating DGI-II and/or DGI-II with deafness.
Career Highlights
Chuan Yu is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has garnered attention for its innovative approach to genetic diagnosis and treatment in dentistry.
Collaborations
Chuan Yu has collaborated with notable colleagues, including Xiangyin Kong and Shangxi Xiao, to advance research in his field. Their combined efforts contribute to the ongoing exploration of genetic conditions and their treatments.
Conclusion
Chuan Yu's contributions to the field of dental genetics, particularly through his patent on diagnosing and treating dentinogenesis imperfecta type II, highlight his role as an innovator in this important area of research. His work continues to pave the way for advancements in genetic diagnosis and treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
